Neuland Laboratories P/B Ratio
Neuland Laboratories (NEULANDLAB) P/B ratio is 11.44 (High), book value per share ₹1442.31 vs Healthcare average P/B of -0.94 — Very High - Significant premium, high growth expectations or speculative. View NEULANDLAB 52-week high low for the annual high/low range and current price position.
Current Valuation Metrics
Book Value Breakdown (2026)
Valuation Signal
Sector Context
NEULANDLAB P/B Ratio — Valuation Insights & Book Value Analysis
Neuland Laboratories price-to-book ratio interpretation, valuation status and historical context — current P/B 11.44 (High). For live price, earnings yield and the full fundamental profile, see Neuland Laboratories screener.
- Stock appears overvalued with PB of 11.44, trading at significant premium to book value
- Trading at high premium to book value - indicates strong growth expectations or asset-light business model
- Trading at premium to sector average PB of -0.94
Neuland Laboratories P/B Ratio Historical Trend
NEULANDLAB annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. Compare with Neuland Laboratories value estimation to assess whether the stock is under or overvalued.
NEULANDLAB Historical P/B Ratio — Book Value Per Share & Year-End Price
Neuland Laboratories annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2026 | 11.57 | ₹1442.31 | ₹16693.00 | ₹1,875 | High |
| 2025 | 12.94 | ₹1173.08 | ₹15175.00 | ₹1,525 | High |
| 2024 | 13.91 | ₹986.92 | ₹13723.80 | ₹1,283 | High |
| 2023 | 6.92 | ₹764.62 | ₹5291.40 | ₹994 | High |
| 2022 | 2.58 | ₹646.92 | ₹1666.95 | ₹841 | Moderate |
NEULANDLAB vs Healthcare Peers — P/B Ratio Comparison
Neuland Laboratories P/B 11.44 vs Healthcare average -0.94, median 0.6 — range -31.21–1.03.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Rekvina Laboratories | VINRKLB | -31.21 | ₹25 | Low |
| Sun Pharma Advanced Rese… | SPARC | -16.05 | ₹5,310 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.31 | ₹75 | Low |
| Parmax Pharma | PARMAX | -2.16 | ₹12 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.76 | ₹121 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |